People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Consumers may cycle on and off GLP-1 medications because of financial constraints. These consumers present opportunities for ...

FODMAPs are carbohydrates that are not absorbed well in the intestine. People with gut-related conditions, like IBS, may need ...

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

STAT senior multimedia producer Alex Hogan chats with UCLA's Stuart B. Murray about his research on food noise - what ...

CMS said April 4 it will not move forward with a Biden-era proposal to allow Medicare coverage of GLP-1 drugs when prescribed solely for weight loss. Three notes: 1. While the agency is not ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...